动脉瘤性蛛网膜下腔出血中脑室造瘘相关感染与死亡率趋势:来自全国住院患者样本的数据
该回顾性分析利用全国住院患者样本2000年1月1日至2011年12月31日数据,纳入116,013例动脉瘤性蛛网膜下腔出血住院患者,其中38,163例(32.9%)行脑室外引流。行脑室外引流患者脑室造瘘相关感染年均发生率为7.3/100例,12年间无变化;平均死亡率为19.8/100例,研究期间显著下降。
要点
- 动脉瘤性蛛网膜下腔出血住院患者中32.9%行脑室外引流。
- 脑室外引流患者脑室造瘘相关感染年均7.3/100例,12年无变化。
- 脑室外引流患者平均死亡率19.8/100例,研究期间显著下降。
核心结论
- 尽管采用多种脑室造瘘相关感染预防策略,动脉瘤性蛛网膜下腔出血患者全国脑室造瘘相关感染率未变化,但死亡率下降被提示。
- 需进一步研究以确定降低脑室造瘘相关感染的最佳方法,并识别影响观察到的脑室造瘘相关感染和死亡率趋势的因素。
研究设计与样本
- 回顾性分析,使用全国住院患者样本2000年1月1日至2011年12月31日数据,采用国际疾病分类第九版临床修订编码。
- 共116,013例动脉瘤性蛛网膜下腔出血住院,其中38,163例(32.9%)行脑室外引流。
- 调整年龄、性别、种族和蛛网膜下腔出血严重程度后,计算脑室造瘘相关感染、院内死亡率和住院时长的年度估计事件率。
主要发现
- 行脑室外引流患者脑室造瘘相关感染年均发生率为7.3/100例,12年间无变化(每年绝对风险降低-0.05%,95%CI -0.22至0.13)。
- 行脑室外引流患者平均死亡率为19.8/100例,研究期间显著下降(每年绝对风险降低-0.55%,95%CI -0.82至-0.29)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with aneurysmal subarachnoid hemorrhage (aSAH) are susceptible to various medical complications, including ventriculostomy-associated infections (VAIs) in those who undergo external ventricular drain (EVD) placement. Many preventative strategies for VAIs have been used during the last 20 years, but their overall effect is unknown. Using the Nationwide (National) Inpatient Sample, we examined trends in VAI rates and mortality during a recent 12-year period in the aSAH population. METHODS: In this retrospective analysis, data from the Nationwide Inpatient Sample was obtained from January 1, 2000, through December 31, 2011, using International Classification of Diseases, 9th Revision, Clinical Modification codes. After adjustment for age, sex, race, and subarachnoid severity, annual estimated event rates of VAI, in-hospital mortality, and hospital length of stay were calculated. Changes in these parameters during the study period were analyzed. RESULTS: From years 2000 through 2011, there were 116,013 aSAH admissions, with EVD placement in 38,163 (32.9%) cases. In patients who underwent EVD placement, the mean annual rate of VAI was 7.3 per 100 patients, with no change during the 12-year period (absolute risk reduction per year of -0.05%, 95% confidence interval -0.22, 0.13). The mean mortality rate in this population was 19.8 per 100 patients, significantly declining over the study period (absolute risk reduction per year of -0.55%, 95% confidence interval -0.82, -0.29). CONCLUSIONS: Despite numerous VAI-preventative strategies, the national VAI rate in aSAH patients has not changed; however, a reduction in mortality is suggested. Further studies are needed to determine how best to reduce VAIs, and to identify factors influencing observed trends in VAI and mortality.
引用
- Poblete R, Zheng L, Raghavan R, et al. Trends in Ventriculostomy-Associated Infections and Mortality in Aneurysmal Subarachnoid Hemorrhage: Data From the Nationwide Inpatient Sample. World Neurosurg. 2016. PMID: 28034809. doi:10.1016/j.wneu.2016.12.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。